---
title: mRNA CROs in United States
path: /modalities/mrna/us
companies_count: 10
---

# mRNA CROs in United States

10 published CROs match mRNA in United States.

Locations in this set include United States, China, India, Netherlands, South Korea, and 30 countries.

Capabilities that show up most often in this set: Analytical Method Development & Validation, Bioanalysis, Translational Research, LC-MS Bioanalysis (Small Molecule), and Biomarker Assays.

## Matching companies

- [Amador Bioscience](/companies/amadorbioscience)
  - Amador Bioscience provides bioanalysis and biomarker services, including LCMS, immunoassays, flow cytometry, and immunogenicity testing, alongside clinical pharmacology modeling and regulatory affairs support. Its labs are GLP compliant, and its teams work across the US, China, and Europe.
- [Aragen Life Sciences](/companies/aragen)
  - Global CRDMO partner offering integrated discovery-to-commercialization services across small molecules and biologics, with 4000+ scientists and R&D/manufacturing campuses in Asia, North America, and Europe.
- [BA Sciences](/companies/basciences)
  - A cGMP-compliant, FDA/DEA-registered, ISO/IEC-17025:2017 certified analytical testing laboratory. It offers analytical method development and validation, raw material and microbiology testing, extractables and leachables, nitrosamines testing, and stability testing for biopharmaceutical, pharmaceutical, and medical device clients.
- [Cassia, LLC](/companies/cassiallc)
  - Cassia, LLC is a San Diego-based CRO specializing in green chemo-enzymatic synthesis of stable-isotope labeled metabolites, proteins, and nucleic acids, plus LC-MS/MS RNA modification mapping services for discovery and therapeutic development.
- [Certara](/companies/certara)
  - Certara transforms drug development with proprietary biosimulation software, predictive modeling, and AI-driven services spanning discovery through commercialization. Serving 2,400+ biopharmaceutical companies and regulatory agencies across 70 countries, Certara's model-informed drug development (MIDD) platform accelerates clinical and regulatory decision-making.
- [Pharmaron](/companies/pharmaron)
  - Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
- [ProBio](/companies/probio)
  - ProBio is a leading global CDMO subsidiary of GenScript Biotech Corporation, providing end-to-end services for biologics and cell & gene therapy (CGT) from drug discovery through commercialization.
- [SoCal Biosciences, Inc.](/companies/socalbiosci)
  - San Diego-based bioanalytical CRO specializing in assay development and analysis for mRNA, oligonucleotides, and large molecules across discovery through clinical development phases.
- [Syngene International](/companies/syngeneintl)
  - Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
- [uBriGene](/companies/ubrigene)
  - uBriGene is a global leader in advanced therapy medicinal products (ATMPs), cell and gene therapy CDMO services, and analytical testing.